...
首页> 外文期刊>Recent patents on endocrine, metabolic & immune drug discovery. >Role of Beta2 Agonists in Respiratory Medicine with Particular Attention to Novel Patents and Effects on Endocrine System and Immune Response
【24h】

Role of Beta2 Agonists in Respiratory Medicine with Particular Attention to Novel Patents and Effects on Endocrine System and Immune Response

机译:Beta 2激动剂在呼吸系统医学中的作用,尤其是对新专利的关注及其对内分泌系统和免疫反应的影响

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Beta adrenergic receptors are very important in respiratory medicine. Traditionally, the stimulation of beta adrenergic receptors by beta2-agonists is commonly used for giving bronchodilation in chronic airflow obstruction However; the wide distribution of these receptors in cells and tissues other than airway smooth muscle suggests that beta agonists should offer other beneficial effects in respiratory disease. Recent studies have shown the importance of these receptors in the modulation of endocrine and immune system that affect respiratory function and may decrease therapy effectiveness in asthma and chronic obstructive pulmonary disease. New patented compound and uses have provided new insights in future therapeutics of respiratory diseases in which genetic, endocrine and immune response should be considered.
机译:β肾上腺素受体在呼吸道医学中非常重要。传统上,β2-激动剂对β肾上腺素能受体的刺激通常用于在慢性气流阻塞中使支气管扩张。这些受体在气道平滑肌以外的细胞和组织中的广泛分布表明,β激动剂应在呼吸系统疾病中提供其他有益作用。最近的研究表明,这些受体在调节内分泌和免疫系统中发挥重要作用,影响呼吸功能,并可能降低哮喘和慢性阻塞性肺疾病的治疗效果。新的专利化合物及其用途为呼吸系统疾病的未来治疗提供了新的见解,在呼吸系统疾病中应考虑遗传,内分泌和免疫反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号